2143 Regorafenib for previously treated metastatic colorectal cancer (mCRC): Results from 683 Italian patients treated in the open-label phase 3B CONSIGN study. (September 2015) - Ciardiello, F.; Falcone, A.; Cascinu, S.; Sobrero, A.; Boni, C.; Barone, C.; Luppi, G.; Maiello, E.; Siena, S.; Zagonel, V.; Carteni, G.; Constanzo, F. Di; et al.